SlideShare a Scribd company logo
1 of 3
Download to read offline
ISSN 2349-7823
International Journal of Recent Research in Life Sciences (IJRRLS)
Vol. 1, Issue 3, pp: (29-31), Month: October - December 2014, Available at: www.paperpublications.org
Page | 29
Paper Publications
Impact of Rubella on Pregnancy with Respect
to IgM Immunolobulin
CHETNA SAVITA1
, Dr. HEMLATA JHARBADE2
, Dr. G.D SHARMA3
1
Asst. Prof. Department of Zoology, P.M.B. Gujarati science college Indore (M.P.), India
2
Asst. Prof. Department of Obstetrics and gynecology, M.G.M Medical college and M.Y. hospital Indore (M.P.), India
3
Asst. Prof. Department Zoology, P.M.B. Gujarati science college Indore (M.P.), India
Abstract: Rubella, though a mild skin infection but show disastrous effects during pregnancy and causes damage to
fetus. The disease is vaccine- preventable diseases can manifest with severe teratogenic effects in fetus known as
congenital rubella syndrome (CRS) due to primary maternal infection such as heart disorders, blindness, deafness
or other life threatening organ disorders. During pregnancy, explore to disease can lead to disastrous results such
as bad obstetric history (BOH), repeated pregnancy loss (RPL) or may cause deformities in fetuses whereas it also
responsible for infertility and maternal mortality. In the study162 women of different background were selected,
out of them 27.16 % of them were found seronegative and were at risk to have Rubella infection. In the study, the
pregnant women show variation in immunity for Rubella according to age. The highest number of susceptible
women was found in age group 21-25 year which is crucial age of conceiving.
Keywords: Teratogenic, Deformities, Seronegative, Immunity, Susceptible.
1. INTRODUCTION
Rubella infection is normally of minor impact characterized by a mild, self-limited disease associated with a characteristic
rash. The incubation period for rubella is 12 to 23 days. The infectious period is from 7 days before to 5–7 days after rash
onset. In the absence of pregnancy, it is usually clinically manifested as a mild self-limited infection. But during
pregnancy, however, the virus can have potentially devastating effects on the developing fetus. It has been directly
responsible for inestimable wastage and for severe congenital malformations. Rubella disease generally has two
symptoms, primary or mild effect and secondary, i.e. CRS (Congenital Rubella Syndrome). While in about 50% of the
cases the infection is silent, but the individual still has the potential to transmit the disease. Generally, the disease
manifests itself with mild symptoms such as fever, rashes, respiratory disorder, joint pain, swollen glands, headache,
conjunctivitis etc., which rarely causes complication in some cases such as arthritis or encephalitis.
Secondary effect (Plotkin, 2001) of the disease is the disastrous one which follows the intrauterine infection by the
Rubella virus and comprises of malformation and complication in the fetus and also shows a bad obstetric history (BOH),
repeated pregnancy loss (RPL) in women whereas it is also responsible for maternal mortality. This is generally caused
due to maternal infection during pregnancy. Due to this fetal infection prematurity, low birth weight and neonatal
thrombocytopenia, anemia and hepatitis can occur. The risk of major defect organogenesis (deformation of organs) is
highest from infection in the first trimester. Mothers who infected by Rubella within the first trimester either have a
miscarriage or a stillborn baby. Even if the baby survives it can be born with severe heart disorders, blindness, deafness or
other life threatening organ disorders. The skin manifestations are called “Blue Berry Muffin Lesions”.
ISSN 2349-7823
International Journal of Recent Research in Life Sciences (IJRRLS)
Vol. 1, Issue 3, pp: (29-31), Month: October - December 2014, Available at: www.paperpublications.org
Page | 30
Paper Publications
2. METHODOLOGY
Study was concerned with the effect of rubella on pregnant women and fetus. Serums of 162 women of age group 16-40
yrs were studied on the basis of rubella immunity (IgM immunoglobulin). A detail obstetric history was taken from these
women with respect to age and obstetric history. All women were grouped as 16-20yrs, 21-25yrs, 26-30yrs, 31-35yrs and
36-40yrs. In study susceptibility percentage of individual group was calculated for IgM immunoglobulin by ELISA test.
3. RESULTS
Figure 1: Number of Susceptible pregnant women according to age groups. (N=162).
S. No. Age (Yrs) N No. of susceptible Susceptibility %
1 16-20 18 8 44.44
2 21-25 88 24 27.27
3 26-30 38 8 21.05
4 31-35 16 2 12.50
5 36-40 2 2 100
Total 16-40 162 44 27.16%
Figure 2: Susceptibility percentage of pregnant women, according to age groups. (N=162)
In study 162 pregnant women were found out of which 27.16% women were found susceptible to rubella (72.84%
immunity). Table-1 shows that the highest percentage (100%) of susceptibility within the groups was found in the age
group 36-40yrs whereas age group 31-35yrs shows the lowest percentage of susceptibility. [Figure-2]
4. DISCUSSION
The majority of women were at high risk at first trimester. In this condition Rubella causes maximum damage to the fetus
and mother. It was found that, in newly married couple’s majorities of woman's face problem in their first trimester
pregnancy or in conceiving. The studies of Gandhoke et al. (1988-2002), Gupta et al. (2003-2004), and Padmaja et al.
(2003-2006) shows 14.6%, 12.8% and 34.3% susceptibility respectively in pregnant women.
In study preference was given to all those women, complaining above problems and it was observed that, women
suffering from primary or secondary infertility and infertility with bad obstetric history shows the highest percentage of
susceptibility.
Pregnant women in the present study show variation in Rubella susceptibility according to different age groups. In study
162 pregnant women were studied and susceptibility against rubella in age groups 16-20years, 21-25years, 26-30years,
31-35years, 36-40years was 44.44%, 27.27%, 21.05%, 12.50% and 100% respectively[figure-1]. Similarly Rubella
susceptibility among different age-groups of pregnant women from Delhi (Seth et al 1972) were reported as 15-19years,
20-24years, 25-29years and 30-34years was 7.1%, 11.6%, 15.5% and 15.4% respectively. Also from the same state by
0.0
20.0
40.0
60.0
80.0
100.0
16-20 21-25 26-30 31-35 36-40
44.44
27.27
21.05
12.50
100.00
Susceptibility%
Age (Years)
ISSN 2349-7823
International Journal of Recent Research in Life Sciences (IJRRLS)
Vol. 1, Issue 3, pp: (29-33), Month: October - December 2014, Available at: www.paperpublications.org
Page | 31
Paper Publications
Gupta et al (2006) susceptibility in pregnant women of age groups 15-19years, 20-24years, 25-30ears, and >31years was
reported as 7.5%, 10.5%, 13% and 22.5% respectively (for IgG antibody).
5. CONCLUSION
Rubella has become global problem and spreading its arms continuously within developing countries. Disease was term as
mild self limiting skin disease. Its impacts can be easily seen in all age groups as well as on future generation.
ACKNOWLEDGEMENT
I am grateful to Dr G.D. Sharma, the Head of the department P.M.B. gujarati science college Indore and Dr. Hemlata
Jharbade, Assistance professor, department of obstetrics and gynecology, M.G.M. college Indore for the guidance &
support throughout the experimental studies. Also I would like to thank the technicians for their help & support during the
course of experimental work.
REFERENCES
[1] Centers for Disease Control (1990). Rubella prevention. Recommendations of the Immunization Practices
Advisory Committee (ACIP). MMWR Recomm Rep ; 39(RR-15):1–18.
[2] Gandhoke I, Aggarwal A, Lal S, Khare S (2005). Seroprevalence and incidence of Rubella in and around Delhi
(1988-2002.) Indian J Med Microbiol; 23:164-7.
[3] Gupta E, Dar L, Broor S (2003). Seroprevalence of rubella in pregnant women in Delhi, India. Ind J Med Res;
123:833-5.
[4] Gupta E, Dar L, Broor S (2006). Seroprevalence of rubella in pregnant women in Delhi, India. Indian J Med Res.;
123:833-5.
[5] Health Care Guideline (2010). Routine Perantal Care. Fourteenth Edition: By the Institute for Clinical Systems,
Improvement July 2010. Health Organization, 75:55-68.
[6] Padmaja M, Radhakrishna PM, Varghese SJ (2010). Seroprevalence of immunity to rubella in pregnant women.
Natl Med J India.;23:248-9.
[7] Plotkin SA (2001). Rubella eradication Vaccine 9 (25-26): 3311–9.
[8] Seth P, Balaya S, Mohapatra LN (1972). Rubella antibody in pregnant women. Indian J Pathol Bacteriol. 1972;
15:23-6.

More Related Content

What's hot

Brucelosis
BrucelosisBrucelosis
Brucelosis
ppmend2a
 
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
Dr. Aisha M Elbareg
 
PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...
PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...
PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...
IAEME Publication
 
Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...
Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...
Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...
Healthcare and Medical Sciences
 
Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...
Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...
Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...
Lifecare Centre
 
Intermittent Preventive Treatment of Malaria in African Infants.
Intermittent Preventive Treatment of Malaria in African Infants.Intermittent Preventive Treatment of Malaria in African Infants.
Intermittent Preventive Treatment of Malaria in African Infants.
Mukhtar Ijaiya
 

What's hot (16)

Brucelosis
BrucelosisBrucelosis
Brucelosis
 
Allergies In Africa Peter SCHMID-GRENDELMEIER
Allergies In Africa   Peter SCHMID-GRENDELMEIERAllergies In Africa   Peter SCHMID-GRENDELMEIER
Allergies In Africa Peter SCHMID-GRENDELMEIER
 
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospitalppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
 
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
 
H0506034045
H0506034045H0506034045
H0506034045
 
Flu vaccine in Pregnancy , Dr. sharda jain , Life Care Centre
Flu vaccine in Pregnancy , Dr. sharda jain , Life Care Centre Flu vaccine in Pregnancy , Dr. sharda jain , Life Care Centre
Flu vaccine in Pregnancy , Dr. sharda jain , Life Care Centre
 
PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...
PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...
PREVALENCE AND DEGREE OF INFECTION OF TOXOCARIASIS IN DAIRY CALVES (HOLSTEIN ...
 
Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...
Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...
Socio-Demography Characteristics and Prevalence of Brucellosis Among Communit...
 
IJSRED-V2I1P8
IJSRED-V2I1P8IJSRED-V2I1P8
IJSRED-V2I1P8
 
Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...
Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...
Infections and vaccines in Pregnancy : An Overview, Dr. Sharda Jain Lifecare...
 
Safety Of the Influenza vaccine In pregnancy
Safety Of the Influenza  vaccine In pregnancy Safety Of the Influenza  vaccine In pregnancy
Safety Of the Influenza vaccine In pregnancy
 
A population based study of measles, mumps,
A population based study of measles, mumps,A population based study of measles, mumps,
A population based study of measles, mumps,
 
Rotavirus vaccines in India - Whats new in 2021
Rotavirus vaccines in India - Whats new in 2021 Rotavirus vaccines in India - Whats new in 2021
Rotavirus vaccines in India - Whats new in 2021
 
Intermittent Preventive Treatment of Malaria in African Infants.
Intermittent Preventive Treatment of Malaria in African Infants.Intermittent Preventive Treatment of Malaria in African Infants.
Intermittent Preventive Treatment of Malaria in African Infants.
 
Food & Acne: Myth or Facts???
Food & Acne: Myth or Facts???Food & Acne: Myth or Facts???
Food & Acne: Myth or Facts???
 
725
725725
725
 

Similar to Impact of Rubella on Pregnancy With Respect To Igm Immunolobulin

HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
Lifecare Centre
 
Perception about tularemia and its awareness among biotechnologists
Perception about tularemia and its awareness among biotechnologistsPerception about tularemia and its awareness among biotechnologists
Perception about tularemia and its awareness among biotechnologists
BRNSSPublicationHubI
 
Pelvic tuberculosis and infertility trivandrum 31.8.13
Pelvic tuberculosis and infertility trivandrum 31.8.13Pelvic tuberculosis and infertility trivandrum 31.8.13
Pelvic tuberculosis and infertility trivandrum 31.8.13
Abha Majumdar
 

Similar to Impact of Rubella on Pregnancy With Respect To Igm Immunolobulin (20)

MMR vaccination for women DR. SHARDA JAIN
MMR vaccinationfor women DR. SHARDA JAIN MMR vaccinationfor women DR. SHARDA JAIN
MMR vaccination for women DR. SHARDA JAIN
 
SPORADIC OUTBREAK CASES OF DIPHTHERIA: A THREE YEARS’ STUDY IN A TERTIARY CAR...
SPORADIC OUTBREAK CASES OF DIPHTHERIA: A THREE YEARS’ STUDY IN A TERTIARY CAR...SPORADIC OUTBREAK CASES OF DIPHTHERIA: A THREE YEARS’ STUDY IN A TERTIARY CAR...
SPORADIC OUTBREAK CASES OF DIPHTHERIA: A THREE YEARS’ STUDY IN A TERTIARY CAR...
 
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
 
Tuberculosis and pregnancy
Tuberculosis and pregnancyTuberculosis and pregnancy
Tuberculosis and pregnancy
 
EVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALES
EVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALESEVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALES
EVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALES
 
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
 
Perception about tularemia and its awareness among biotechnologists
Perception about tularemia and its awareness among biotechnologistsPerception about tularemia and its awareness among biotechnologists
Perception about tularemia and its awareness among biotechnologists
 
WOMEN AND IMMUNISATION PROMOTING ADOLESCENT / ADULT WOMEN IMMUNIZATION DR....
WOMEN  AND IMMUNISATION PROMOTING ADOLESCENT / ADULT  WOMEN IMMUNIZATION  DR....WOMEN  AND IMMUNISATION PROMOTING ADOLESCENT / ADULT  WOMEN IMMUNIZATION  DR....
WOMEN AND IMMUNISATION PROMOTING ADOLESCENT / ADULT WOMEN IMMUNIZATION DR....
 
Dengue infection in pregnancy
Dengue infection in pregnancy Dengue infection in pregnancy
Dengue infection in pregnancy
 
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
 
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
 
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
Involvement of Helicobacter Pylori in the Genesis of Precancerous Stomach Les...
 
Cervical lymph node enlargement
Cervical lymph node enlargementCervical lymph node enlargement
Cervical lymph node enlargement
 
Cervical lymph node enlargement
Cervical lymph node enlargementCervical lymph node enlargement
Cervical lymph node enlargement
 
Cervical lymph node enlargement
Cervical lymph node enlargementCervical lymph node enlargement
Cervical lymph node enlargement
 
Rubella
RubellaRubella
Rubella
 
Vaccination in women form womb to tomb
Vaccination in women form womb to tombVaccination in women form womb to tomb
Vaccination in women form womb to tomb
 
Dr girija wagh vaccination in women form womb to tomb ADBHUT MATRUTVA
Dr girija wagh   vaccination in women form womb to tomb ADBHUT MATRUTVADr girija wagh   vaccination in women form womb to tomb ADBHUT MATRUTVA
Dr girija wagh vaccination in women form womb to tomb ADBHUT MATRUTVA
 
Rubella
RubellaRubella
Rubella
 
Pelvic tuberculosis and infertility trivandrum 31.8.13
Pelvic tuberculosis and infertility trivandrum 31.8.13Pelvic tuberculosis and infertility trivandrum 31.8.13
Pelvic tuberculosis and infertility trivandrum 31.8.13
 

Recently uploaded

Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
GOWTHAMIM22
 
Tuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notesTuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notes
jyothisaisri
 
Heat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree daysHeat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree days
Brahmesh Reddy B R
 

Recently uploaded (20)

The Scientific names of some important families of Industrial plants .pdf
The Scientific names of some important families of Industrial plants .pdfThe Scientific names of some important families of Industrial plants .pdf
The Scientific names of some important families of Industrial plants .pdf
 
Biochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptx
Biochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptxBiochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptx
Biochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptx
 
GBSN - Microbiology (Unit 6) Human and Microbial interaction
GBSN - Microbiology (Unit 6) Human and Microbial interactionGBSN - Microbiology (Unit 6) Human and Microbial interaction
GBSN - Microbiology (Unit 6) Human and Microbial interaction
 
GBSN - Microbiology (Unit 7) Microbiology in Everyday Life
GBSN - Microbiology (Unit 7) Microbiology in Everyday LifeGBSN - Microbiology (Unit 7) Microbiology in Everyday Life
GBSN - Microbiology (Unit 7) Microbiology in Everyday Life
 
Plasmapheresis - Dr. E. Muralinath - Kalyan . C.pptx
Plasmapheresis - Dr. E. Muralinath - Kalyan . C.pptxPlasmapheresis - Dr. E. Muralinath - Kalyan . C.pptx
Plasmapheresis - Dr. E. Muralinath - Kalyan . C.pptx
 
Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
 
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdfFORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
 
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 RpWASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
 
Tuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notesTuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notes
 
Developing Distributed High-performance Computing Capabilities of an Open Sci...
Developing Distributed High-performance Computing Capabilities of an Open Sci...Developing Distributed High-performance Computing Capabilities of an Open Sci...
Developing Distributed High-performance Computing Capabilities of an Open Sci...
 
Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...
Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...
Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...
 
Lubrication System in forced feed system
Lubrication System in forced feed systemLubrication System in forced feed system
Lubrication System in forced feed system
 
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
 
Information science research with large language models: between science and ...
Information science research with large language models: between science and ...Information science research with large language models: between science and ...
Information science research with large language models: between science and ...
 
Plasma proteins_ Dr.Muralinath_Dr.c. kalyan
Plasma proteins_ Dr.Muralinath_Dr.c. kalyanPlasma proteins_ Dr.Muralinath_Dr.c. kalyan
Plasma proteins_ Dr.Muralinath_Dr.c. kalyan
 
Heat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree daysHeat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree days
 
Introduction and significance of Symbiotic algae
Introduction and significance of  Symbiotic algaeIntroduction and significance of  Symbiotic algae
Introduction and significance of Symbiotic algae
 
THE GENERAL PROPERTIES OF PROTEOBACTERIA AND ITS TYPES
THE GENERAL PROPERTIES OF PROTEOBACTERIA AND ITS TYPESTHE GENERAL PROPERTIES OF PROTEOBACTERIA AND ITS TYPES
THE GENERAL PROPERTIES OF PROTEOBACTERIA AND ITS TYPES
 
MODERN PHYSICS_REPORTING_QUANTA_.....pdf
MODERN PHYSICS_REPORTING_QUANTA_.....pdfMODERN PHYSICS_REPORTING_QUANTA_.....pdf
MODERN PHYSICS_REPORTING_QUANTA_.....pdf
 
Factor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandFactor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary Gland
 

Impact of Rubella on Pregnancy With Respect To Igm Immunolobulin

  • 1. ISSN 2349-7823 International Journal of Recent Research in Life Sciences (IJRRLS) Vol. 1, Issue 3, pp: (29-31), Month: October - December 2014, Available at: www.paperpublications.org Page | 29 Paper Publications Impact of Rubella on Pregnancy with Respect to IgM Immunolobulin CHETNA SAVITA1 , Dr. HEMLATA JHARBADE2 , Dr. G.D SHARMA3 1 Asst. Prof. Department of Zoology, P.M.B. Gujarati science college Indore (M.P.), India 2 Asst. Prof. Department of Obstetrics and gynecology, M.G.M Medical college and M.Y. hospital Indore (M.P.), India 3 Asst. Prof. Department Zoology, P.M.B. Gujarati science college Indore (M.P.), India Abstract: Rubella, though a mild skin infection but show disastrous effects during pregnancy and causes damage to fetus. The disease is vaccine- preventable diseases can manifest with severe teratogenic effects in fetus known as congenital rubella syndrome (CRS) due to primary maternal infection such as heart disorders, blindness, deafness or other life threatening organ disorders. During pregnancy, explore to disease can lead to disastrous results such as bad obstetric history (BOH), repeated pregnancy loss (RPL) or may cause deformities in fetuses whereas it also responsible for infertility and maternal mortality. In the study162 women of different background were selected, out of them 27.16 % of them were found seronegative and were at risk to have Rubella infection. In the study, the pregnant women show variation in immunity for Rubella according to age. The highest number of susceptible women was found in age group 21-25 year which is crucial age of conceiving. Keywords: Teratogenic, Deformities, Seronegative, Immunity, Susceptible. 1. INTRODUCTION Rubella infection is normally of minor impact characterized by a mild, self-limited disease associated with a characteristic rash. The incubation period for rubella is 12 to 23 days. The infectious period is from 7 days before to 5–7 days after rash onset. In the absence of pregnancy, it is usually clinically manifested as a mild self-limited infection. But during pregnancy, however, the virus can have potentially devastating effects on the developing fetus. It has been directly responsible for inestimable wastage and for severe congenital malformations. Rubella disease generally has two symptoms, primary or mild effect and secondary, i.e. CRS (Congenital Rubella Syndrome). While in about 50% of the cases the infection is silent, but the individual still has the potential to transmit the disease. Generally, the disease manifests itself with mild symptoms such as fever, rashes, respiratory disorder, joint pain, swollen glands, headache, conjunctivitis etc., which rarely causes complication in some cases such as arthritis or encephalitis. Secondary effect (Plotkin, 2001) of the disease is the disastrous one which follows the intrauterine infection by the Rubella virus and comprises of malformation and complication in the fetus and also shows a bad obstetric history (BOH), repeated pregnancy loss (RPL) in women whereas it is also responsible for maternal mortality. This is generally caused due to maternal infection during pregnancy. Due to this fetal infection prematurity, low birth weight and neonatal thrombocytopenia, anemia and hepatitis can occur. The risk of major defect organogenesis (deformation of organs) is highest from infection in the first trimester. Mothers who infected by Rubella within the first trimester either have a miscarriage or a stillborn baby. Even if the baby survives it can be born with severe heart disorders, blindness, deafness or other life threatening organ disorders. The skin manifestations are called “Blue Berry Muffin Lesions”.
  • 2. ISSN 2349-7823 International Journal of Recent Research in Life Sciences (IJRRLS) Vol. 1, Issue 3, pp: (29-31), Month: October - December 2014, Available at: www.paperpublications.org Page | 30 Paper Publications 2. METHODOLOGY Study was concerned with the effect of rubella on pregnant women and fetus. Serums of 162 women of age group 16-40 yrs were studied on the basis of rubella immunity (IgM immunoglobulin). A detail obstetric history was taken from these women with respect to age and obstetric history. All women were grouped as 16-20yrs, 21-25yrs, 26-30yrs, 31-35yrs and 36-40yrs. In study susceptibility percentage of individual group was calculated for IgM immunoglobulin by ELISA test. 3. RESULTS Figure 1: Number of Susceptible pregnant women according to age groups. (N=162). S. No. Age (Yrs) N No. of susceptible Susceptibility % 1 16-20 18 8 44.44 2 21-25 88 24 27.27 3 26-30 38 8 21.05 4 31-35 16 2 12.50 5 36-40 2 2 100 Total 16-40 162 44 27.16% Figure 2: Susceptibility percentage of pregnant women, according to age groups. (N=162) In study 162 pregnant women were found out of which 27.16% women were found susceptible to rubella (72.84% immunity). Table-1 shows that the highest percentage (100%) of susceptibility within the groups was found in the age group 36-40yrs whereas age group 31-35yrs shows the lowest percentage of susceptibility. [Figure-2] 4. DISCUSSION The majority of women were at high risk at first trimester. In this condition Rubella causes maximum damage to the fetus and mother. It was found that, in newly married couple’s majorities of woman's face problem in their first trimester pregnancy or in conceiving. The studies of Gandhoke et al. (1988-2002), Gupta et al. (2003-2004), and Padmaja et al. (2003-2006) shows 14.6%, 12.8% and 34.3% susceptibility respectively in pregnant women. In study preference was given to all those women, complaining above problems and it was observed that, women suffering from primary or secondary infertility and infertility with bad obstetric history shows the highest percentage of susceptibility. Pregnant women in the present study show variation in Rubella susceptibility according to different age groups. In study 162 pregnant women were studied and susceptibility against rubella in age groups 16-20years, 21-25years, 26-30years, 31-35years, 36-40years was 44.44%, 27.27%, 21.05%, 12.50% and 100% respectively[figure-1]. Similarly Rubella susceptibility among different age-groups of pregnant women from Delhi (Seth et al 1972) were reported as 15-19years, 20-24years, 25-29years and 30-34years was 7.1%, 11.6%, 15.5% and 15.4% respectively. Also from the same state by 0.0 20.0 40.0 60.0 80.0 100.0 16-20 21-25 26-30 31-35 36-40 44.44 27.27 21.05 12.50 100.00 Susceptibility% Age (Years)
  • 3. ISSN 2349-7823 International Journal of Recent Research in Life Sciences (IJRRLS) Vol. 1, Issue 3, pp: (29-33), Month: October - December 2014, Available at: www.paperpublications.org Page | 31 Paper Publications Gupta et al (2006) susceptibility in pregnant women of age groups 15-19years, 20-24years, 25-30ears, and >31years was reported as 7.5%, 10.5%, 13% and 22.5% respectively (for IgG antibody). 5. CONCLUSION Rubella has become global problem and spreading its arms continuously within developing countries. Disease was term as mild self limiting skin disease. Its impacts can be easily seen in all age groups as well as on future generation. ACKNOWLEDGEMENT I am grateful to Dr G.D. Sharma, the Head of the department P.M.B. gujarati science college Indore and Dr. Hemlata Jharbade, Assistance professor, department of obstetrics and gynecology, M.G.M. college Indore for the guidance & support throughout the experimental studies. Also I would like to thank the technicians for their help & support during the course of experimental work. REFERENCES [1] Centers for Disease Control (1990). Rubella prevention. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep ; 39(RR-15):1–18. [2] Gandhoke I, Aggarwal A, Lal S, Khare S (2005). Seroprevalence and incidence of Rubella in and around Delhi (1988-2002.) Indian J Med Microbiol; 23:164-7. [3] Gupta E, Dar L, Broor S (2003). Seroprevalence of rubella in pregnant women in Delhi, India. Ind J Med Res; 123:833-5. [4] Gupta E, Dar L, Broor S (2006). Seroprevalence of rubella in pregnant women in Delhi, India. Indian J Med Res.; 123:833-5. [5] Health Care Guideline (2010). Routine Perantal Care. Fourteenth Edition: By the Institute for Clinical Systems, Improvement July 2010. Health Organization, 75:55-68. [6] Padmaja M, Radhakrishna PM, Varghese SJ (2010). Seroprevalence of immunity to rubella in pregnant women. Natl Med J India.;23:248-9. [7] Plotkin SA (2001). Rubella eradication Vaccine 9 (25-26): 3311–9. [8] Seth P, Balaya S, Mohapatra LN (1972). Rubella antibody in pregnant women. Indian J Pathol Bacteriol. 1972; 15:23-6.